Login (Lost Password?)
Username:
Password:
Remember my password.

CDC/ Update on Japanese Encephalitis Vaccines/ Health Canada notice of decision for IXIARO®

CDC: Announcement: January 25th, 2010

There are currently two Japanese encephalitis (JE) vaccines available in the United States: JE-VAX^® (distributed by sanofi pasteur) and IXIARO^® (distributed by Novartis Vaccines).

For more informations: http://wwwnc.cdc.gov/travel/content/news-announcements/update-japanese-encephalitis-vaccines.aspx

See also : Health Canada: Notice of Decision for IXIARO^®

On October 29, 2009, Health Canada issued a Notice of Compliance to Intercell AG for the vaccine Ixiaro^®. Ixiaro^® is a purified and inactivated Japanese encephalitis whole virus vaccine derived from the attenuated Japanese encephalitis virus strain SA₁₄-14-2. Ixiaro^® is indicated for active immunization against Japanese encephalitis for
persons 18 years of age and older.

For more informations: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/phase1-decision/drug-med/nd_ad_2009_ixiaro_120330-eng.php

Last Modified Date: 26/01/2010 10:03:17 AM

Created by LS2